Follow
Alex Louie
Alex Louie
Sunnybrook Health Sciences Centre
Verified email at sunnybrook.ca - Homepage
Title
Cited by
Cited by
Year
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...
The Lancet 393 (10185), 2051-2058, 2019
17442019
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
JY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ...
The lancet oncology 16 (6), 630-637, 2015
16392015
Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: long-term results of a multi-institutional …
DR Gomez, C Tang, J Zhang, GR Blumenschein Jr, M Hernandez, JJ Lee, ...
Journal of Clinical Oncology 37 (18), 1558-1565, 2019
11622019
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic …
DR Gomez, GR Blumenschein, JJ Lee, M Hernandez, R Ye, DR Camidge, ...
The lancet oncology 17 (12), 1672-1682, 2016
10852016
Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial
DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...
Journal of Clinical Oncology 38 (25), 2830-2838, 2020
9832020
Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke
DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ...
American journal of preventive medicine 20 (2), 16-66, 2001
3382001
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
DA Palma, R Olson, S Harrow, RJM Correa, F Schneiders, CJA Haasbeek, ...
BMC cancer 19, 1-15, 2019
2212019
Management of metastatic clear cell renal cell carcinoma: ASCO guideline
WK Rathmell, RB Rumble, PJ Van Veldhuizen, H Al-Ahmadie, ...
Journal of Clinical Oncology 40 (25), 2957-2995, 2022
1872022
Detection of local cancer recurrence after stereotactic ablative radiation therapy for lung cancer: physician performance versus radiomic assessment
SA Mattonen, DA Palma, C Johnson, AV Louie, M Landis, G Rodrigues, ...
International Journal of Radiation Oncology* Biology* Physics 94 (5), 1121-1128, 2016
1692016
Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)
S Siva, AV Louie, A Warner, A Muacevic, S Gandhidasan, L Ponsky, ...
Cancer 124 (5), 934-942, 2018
1672018
Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review
H Chen, S Senan, EJ Nossent, RG Boldt, A Warner, DA Palma, AV Louie
International Journal of Radiation Oncology* Biology* Physics 98 (3), 622-631, 2017
1482017
Inter-observer and intra-observer reliability for lung cancer target volume delineation in the 4D-CT era
AV Louie, G Rodrigues, J Olsthoorn, D Palma, E Yu, B Yaremko, B Ahmad, ...
Radiotherapy and Oncology 95 (2), 166-171, 2010
1482010
Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended long-term outcomes
S Harrow, DA Palma, R Olson, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...
International Journal of Radiation Oncology* Biology* Physics 114 (4), 611-616, 2022
1442022
Post-treatment mortality after surgery and stereotactic body radiotherapy for early-stage non–small-cell lung cancer
WA Stokes, MR Bronsert, RA Meguid, MG Blum, BL Jones, M Koshy, ...
Journal of clinical oncology 36 (7), 642-651, 2018
1362018
Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach
S Siva, G Kothari, A Muacevic, AV Louie, BJ Slotman, BS Teh, SS Lo
Nature Reviews Urology 14 (9), 549-563, 2017
1362017
Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons
AV Louie, DA Palma, M Dahele, GB Rodrigues, S Senan
Radiotherapy and Oncology 114 (2), 138-147, 2015
1312015
Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies
NG Zaorsky, EJ Lehrer, G Kothari, AV Louie, S Siva
European urology oncology 2 (5), 515-523, 2019
1302019
The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: a systematic review and meta-analysis
RJM Correa, AV Louie, NG Zaorsky, EJ Lehrer, R Ellis, L Ponsky, I Kaplan, ...
European urology focus 5 (6), 958-969, 2019
1272019
Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): results of a randomized trial
DA Palma, RA Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, ...
International Journal of Radiation Oncology, Biology, Physics 102 (3), S3-S4, 2018
1222018
Epidemiology of bone metastases
C Ryan, KC Stoltzfus, S Horn, H Chen, AV Louie, EJ Lehrer, DM Trifiletti, ...
Bone 158, 115783, 2022
1182022
The system can't perform the operation now. Try again later.
Articles 1–20